Dr. Christian Kollmannsberger, MD, FRCPC
Clinical Associate Professor of Medicine, Div. of Medical Oncology
University of British Columbia, BCCA Vancouver Cancer Centre

Dr. Kollmannsberger has been a staff Medical Oncologist at the British Columbia Cancer Agency (BCCA) Vancouver Cancer Centre since February 2004 and a Clinical Associate Professor at the University of British Columbia since January of 2006. Dr. Kollmannsberger graduated from the Technical University in Munich, Germany and received his clinical training in Internal Medicine, Hematology and Medical Oncology mainly at the University of Tuebingen, Germany.

Dr. Kollmannsberger’s research is focused on genitourinary malignancies with a special interest in testicular and renal cell cancer as well as gastrointestinal cancers, in particular upper GI malignancies. This includes phase I, II and III clinical trials, the development of new therapeutic options and investigation of mechanisms of treatment resistance. Nationally and internationally, he has contributed to numerous trials in the field.

Dr. Kollmannsberger’s research has been published in peer-reviewed journals that include the Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, European Journal of Cancer, Cancer and British Journal of Cancer amongst others. He has served on faculty for international conferences such as the Annual Meeting of the American Society of Clinical Oncology (ASCO), the ASCO Genitourinary Cancers Symposium, the Annual Meeting of the European Society of Medical Oncology (ESMO), the EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics” and served as a member of the organizing committee for the Canadian Kidney Cancer Forum.

Dr. Kollmannsberger currently serves as the chair of the BCCA Genitourinary Cancers Systemic
Therapy Group, the co-chair for the Genitourinary and Phase I Clinical Trials Unit at the BC Cancer Agency – Vancouver Centre as well as the Chair for the National Cancer Institute of Canada Testis Cancer Disease Oriented Group and the Cop-Chair for the National Cancer Institute of Canada Esophageal and Gastric Cancer Disease Oriented Group.